← SynDRA
VATALANIB
SynDRA canonical compound SYN0003902 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PDGFRB |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
- FLT1
- FLT4
- KDR
- PDGFRB
- KIT
- EGFR
- PDGFRA
- CSF1R
- CYP19A1
Mechanisms of action (all sources)
- KIT INHIBITOR
- PDGFR inhibitor
- VEGFR inhibitor
- Stem cell growth factor receptor inhibitor
- PDGFRB INHIBITOR
- Platelet-derived growth factor receptor inhibitor
- PDGFRA INHIBITOR
- FLT1 INHIBITOR
- Vascular endothelial growth factor receptor inhibitor
- FLT4 INHIBITOR
- KDR INHIBITOR
- CSF1R INHIBITOR
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- Vatalanib succinate
- Ptk-787
- BAY-86-5127
- CGP-79787
- K-222584
- NVP-PTK787
- PTK787
- ZK-222584
- ZK222584
- Vatalanib base
- N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine
- Pynasunate
- Vatalanib free base
- PTK-787
- Vatalanib (free base)
- Vatalinib
- ZK-232934
- PTK/ZK
- CHEMBL101253
- N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine
- UNII-5DX9U76296
- CHEBI:90620
- YCOYDOIWSSHVCK-UHFFFAOYSA-N
- 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine
- 5DX9U76296
- NCGC00181350-01
- 1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-
- DSSTox_CID_26919
- Ptk 787
- Vatalanib (dihydrochloride)
- PTK787 dihydrochloride;CGP-797870 dihydrochloride;ZK-222584 dihydrochloride
- CAS-212141-54-3
- SR-05000001457
- PTK/ZK free base
- Vatalanib [USAN]
- 1 -(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine
- PTK787 free base
Look up VATALANIB in the interactive SynDRA portal →